Shelat, H S; Liu, T J; Hickman-Bick, D L et al. (2001) Growth suppression of human coronary vascular smooth muscle cells by gene transfer of the transcription factor E2F-1. Circulation 103:407-14
|
Zoldhelyi, P; Chen, Z Q; Shelat, H S et al. (2001) Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci U S A 98:4078-83
|
Jax, T W; Eichstaedt, H C; Shelat, H S et al. (2000) [New antithrombotic therapy approaches in coronary heart disease--prospects for gene therapy] Z Kardiol 89:1072-83
|
Zoldhelyi, P; Beck, P J; Bjercke, R J et al. (2000) Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor. Am J Physiol Heart Circ Physiol 279:H3065-75
|
Zoldhelyi, P; Eichstaedt, H; Jax, T et al. (1999) The emerging clinical potential of cardiovascular gene therapy. Semin Interv Cardiol 4:151-65
|
Patel, S S; Thiagarajan, R; Willerson, J T et al. (1998) Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation 97:75-81
|
Pakala, R; Willerson, J T; Benedict, C R (1997) Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation 96:2280-6
|
Willerson, J T; Igo, S R; Yao, S K et al. (1996) Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries. Tex Heart Inst J 23:1-8
|
Willerson, J T; Zoldhelyi, P; Meidell, R et al. (1995) Gene therapy to restore prostacyclin presence to injured endothelium. Trans Am Clin Climatol Assoc 106:100-7;discussion 107-8
|
Yao, S K; Akhtar, S; Scott-Burden, T et al. (1995) Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. Circulation 92:1005-10
|
Showing the most recent 10 out of 14 publications